PDG3 ANTI-VEGF DRUGS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - A SYSTEMATIC REVIEW OF THE IMPACT OF ANTI-VEGF THERAPY ON REDUCING BLINDNESS AND VISUAL IMPAIRMENT
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1017
https://www.valueinhealthjournal.com/article/S1098-3015(19)33395-9/fulltext
Title :
PDG3 ANTI-VEGF DRUGS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - A SYSTEMATIC REVIEW OF THE IMPACT OF ANTI-VEGF THERAPY ON REDUCING BLINDNESS AND VISUAL IMPAIRMENT
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33395-9&doi=10.1016/j.jval.2019.09.1017
First page :
Section Title :
Open access? :
No
Section Order :
10897